Progress in applied chemoprevention research.
Kelloff
G J
GJ
Chemoprevention Branch, National Cancer Institute, Bethesda, MD 20892.
Malone
W F
WF
Boone
C W
CW
Sigman
C C
CC
Fay
J R
JR
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D003687:Dehydroepiandrosterone / Q000031:analogs & derivatives / Q000627:therapeutic use; D004341:Drug Evaluation; D000518:Eflornithine / Q000627:therapeutic use; D017313:Fenretinide; D006801:Humans; D008982:Molybdenum / Q000627:therapeutic use; D009369:Neoplasms / Q000517:prevention & control*; D010894:Piroxicam / Q000627:therapeutic use; D014212:Tretinoin / Q000031:analogs & derivatives / Q000627:therapeutic use
D000970:Antineoplastic Agents; D010894:Piroxicam; D017313:Fenretinide; D003687:Dehydroepiandrosterone; D014212:Tretinoin; D008982:Molybdenum; D000518:Eflornithine